E Fund Management’s Caribou Biosciences CRBU Stock Holding History

E Fund Management’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-25,586	Closed	-$132K	–	334
2024 Q1	$132K	Buy	25,586 +5,235	+26%	+$32.3K	0.01%	361
2023 Q4	$117K	Sell	20,351 -5,714	-22%	-$28.2K	0.01%	299
2023 Q3	$125K	Buy	+26,065	New	+$162K	0.01%	275
2023 Q2	–	Sell	-13,274	Closed	-$70K	–	314
2023 Q1	$70K	Buy	13,274 +2,184	+20%	+$13.6K	0.01%	328
2022 Q4	$70K	Buy	+11,090	New	+$98.7K	0.01%	333

Other funds holding CRBU

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

EWM

Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

E Fund Management's CRBU Position: Q2 2024 in Review

E Fund Management sold out of Caribou Biosciences (CRBU) in Q2 2024, closing a stake of 25,586 shares — an estimated $132K sold.

E Fund Management first reported a position in CRBU in Q4 2022 and held it in 5 quarters. The position peaked at $132K in Q1 2024. 140 funds tracked by Wall St. Rank hold CRBU as of Q2 2024.

E Fund Management reported no remaining Caribou Biosciences position as of Q2 2024 after selling out during the quarter.
E Fund Management sold 25,586 Caribou Biosciences shares in Q2 2024, an estimated $132K.
E Fund Management first reported a position in Caribou Biosciences in Q4 2022 and held it in 5 quarters.
E Fund Management's Caribou Biosciences position peaked at $132K in Q1 2024.
140 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2024.

Based on E Fund Management's 13F filing for Q2 2024, filed 12 Aug 2024.